The anterior cingulate cortex (ACC) is a critical hub for nociceptive perception and pain-related anxiety. Long-term synaptic plasticity in ACC was found to be important for chronic inflammatory pain and pain-related anxiety. As short-term synaptic plasticity, depolarization-induced suppression of excitation (DSE) is involved in several conditions, such as chronic stress, epilepsy, and autism. However, it is still unknown whether DSE in the ACC is involved in the central sensitization of pain and anxiety. Using a whole-cell patch clamp, calcium imaging, western blot, and behavioral testing, we found that DSE was induced by a 2 s depolarization in postsynaptic pyramidal cells in ACC. DSE was mediated by endocannabinoid signaling and modulated by metabotropic glutamate receptor 5 (mGluR5). DSE was impaired by decreasing expression and dysfunction of mGluR5 in a mouse model of inflammatory pain induced by complete Freund's adjuvant. CDPPB, an mGluR5positive allosteric modulator, could rescue hypersensitivity and anxiety-like behavior in this pain model. Our results demonstrated that mGluR5-mediated short-term plasticity in ACC may be a critical mechanism for chronic pain, and mGluR5 may potentially serve as a target of pain therapy, including treatments for hyperalgesia and anxiety.
Introduction
Chronic pain is an unpleasant sensory and emotional experience that lasts over time and is produced by many factors, such as inflammation and damage (Zhuo 2008 ). There has been significant progress in the understanding of mechanisms underlying chronic pain; however, it remains an area of considerable unmet medical need because of the limited number of effective treatments (Kuner 2010) . Therefore, searching for a new target and exploring new intervention methods to manage pain is critical.
Anterior cingulate cortex (ACC) is a critical hub for nociceptive message transmission, which has been demonstrated in clinical research and animal studies (Apkarian et al. 2005; Li et al. 2010) .
Accumulating evidence has also implicated the ACC in painrelated conditions, such as anxiety (Zhuo 2016) , aversion Han et al. 2014) , and depression (Barthas et al. 2015) . The synaptic plasticity in the ACC is causally related to chronic pain and anxiety. Long-term potentiation (LTP) is believed to maintain chronic pain and mediate the interaction between anxiety and chronic pain (Luo et al. 2014; Koga et al. 2015; Bliss et al. 2016) . In addition to long-term plasticity, short-term plasticity also plays a critical role in many brain functions (Zachariou and Thul 2014) . A form of cannabinoid receptor 1 (CB1R)-mediated short-term depression, known as depolarization-induced suppression of excitation (DSE), has been reported to play a functional role in emotional memory processing (Kamprath et al. 2011 ) and conditional fear responses (Kamprath et al. 2011) . Additionally, CB1R was found to be moderately expressed in the ACC (Mailleux and Vanderhaeghen 1992; Tsou et al. 1998 ). However, whether DSE could be induced in the ACC has not been studied previously.
DSE are triggered by postsynaptic neuronal depolarization and facilitated by metabotropic receptor activation (Uchigashima et al. 2007) . DSE requires calcium influx via voltage-gated Ca 2+ channels, which can be amplified by ryanodine-sensitive Ca 2+ stores, and subsequent Ca 2+ stimulated production of 2-arachydonylglycerol (Isokawa and Alger 2006) . After the endocannabinoid (eCB) was produced postsynaptically, it diffuses in a retrograde direction to the presynaptic area and targets CB1R to inhibit neurotransmitter release presynaptically (Straiker et al. 2013) . Previous studies have shown that metabotropic glutamate receptor 5 (mGluR5) was expressed in the ACC and could drive calcium-dependent plateau potentials as well as persistent firing in layers II/III of the ACC, which may be related to pain processing (Zhang and Seguela 2010) . In the ACC, whether mGluR5 plays an important role in DSE, and whether this short-term plasticity would be altered by chronic pain remains unknown.
In this study, we report for the first time that DSE exists in the ACC and it is mediated by CB1R and modulated by mGluR5. Then, we show that DSE was impaired by the decreasing expression and dysfunction of mGluR5 in an inflammatory pain model. Finally, with microinjection of selective mGluR5-positive allosteric modulators into the ACC, we rescue hypersensitivity and anxiety in a model of chronic inflammatory pain. Our results suggest that mGluR5-mediated short-term plasticity impairment may be a critical mechanism for chronic pain.
Materials and Methods

Animals and Pain Model
Adult male C57BL/6 mice (8-12 weeks old) were acquired from the Experimental Animal Center of Fourth Military Medical University (Xi'an, China), and the generation of Thy1-GCaMP3 transgenic mice was performed as described previously ). Thy1-GCaMP3 mice were the progeny of breeding in which only one of the parents expressed the Thy1-GCaMP3 transgenes, and no experimental mice were homozygous for the transgenic fluorescent markers. All experimental animals were housed in groups in a temperature-and humiditycontrolled room with a 12:12 light-dark cycle and water available ad libitum. All experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at the Fourth Military Medical University and conformed to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH). All efforts were made to minimize animal suffering and to reduce the number of animals that were used. The CFA-induced inflammation pain model was established as previously described (Guo et al. 2013) . Mice were injected with 10 μL of CFA (1 mg/mL Mycobacterium Tuberculosis; Sigma, UK) into the plantar surface of the right hind paw to induce inflammation under isoflurane anesthesia for behavior. The mice for electrophysiological recording in brain slice and western blots were injected with same amount of CFA into both hind paws.
Microinjection Cannula Implantation and Microinjection Procedures
Mice were anesthetized with isoflurane in medical grade breathing air at a flow rate of 0.3 L/min and placed in a stereotaxic instrument (RWD Life Science). Bilateral microinjection guide cannulae (26 ga outer diameter (OD)) were aimed to terminate 1 mm dorsal to the ACC. The stereotaxic coordinates of the ACC were anterior/posterior +1.0, medial/lateral ±0.35, and dorsal/ventral -2.2. The microinjection cannulas were secured to the skull with stainless steel screws and dental cement. Then, we inserted removable obturators (33 ga OD) at the full length of the guide cannulae to limit obstruction. Topical 2% xylocaine and 2% triple antibiotic ointments were applied to the wound. Microinjection was performed 30 min before behavioral tests. Mice were lightly restrained and obturators were removed. Sterile 33 ga microinjection needles were connected to two 10 μL syringes (Hamilton) via microbore tubing. The syringes were mounted on a microinfusion pump (Harvard Apparatus) set to deliver fluids at a flow rate of 300 nL/min. Microinjection needles were inserted bilaterally to a depth 1 mm beyond the ventral tip of the guide cannula. Drug solutions were infused in a volume of 300 nL/side over a 1 min period. Then, the microinjection needles remained in place for additional 1 min for drug diffusion. After the diffusion, the injector was removed and the obturators were replaced.
Behavioral Tests
All behavioral tests were performed in awake, unrestrained, age-matched male mice between 8 and 12 weeks old. All tests were performed in an appropriately lighted, quiet room. Behavioral tests were performed in habituated mice by an observer blinded to the identity of the groups.
Nociceptive Behavioral Tests
Mechanical allodynia was assessed by measuring paw withdrawal thresholds (PWTs) in response to a calibrated series of von Frey hairs (0.02-1.4 g). Mice were placed individually into Plexiglas chambers on an elevated wire-mesh floor and a series of von Frey hairs were applied to the plantar surface of hind paw in ascending order with a sufficient force to bend the hair for 2 s or until paw withdrawal. The lowest force in grams that produced at least 3 withdrawal responses in 5 consecutive applications was defined as the PWT. A Hargreaves' test measured the paw withdrawal latencies (PWLs) in response to a radiant heat source (IITC Lifescience Inc., Woodland Hill, CA). PWL was defined as the time from the onset of heat application to the withdrawal of the hind paw.
(SMART 3.0, Panlab S.L.U.). The distance and time spent in the center area were used to evaluate anxiety levels.
Slice Preparation and Electrophysiology Recording
The procedures for preparing ACC slices were prepared as follows: mice were anesthetized with isoflurane and transcardially perfused with 20 mL of ice-cold carbogenated (95% O 2 , 5% CO 2 ) cutting solution containing (in mM): 115 Choline-chloride, 2.5 KCl, 1.25 NaH 2 PO 4 , 0.5 CaCl 2 , 8 MgCl 2 , 26 NaHCO 3 , 10 D-(+)-glucose 0.1 L-ascorbic acid, and 0.4 sodium pyruvate (with an osmolarity of 300-305 mOsm). The brains were then rapidly removed and placed in an ice-cold cutting solution for slice preparation. The coronal slices (300 μm) containing the ACC (Bregma 1.3-0.5 mm) were prepared using a slicer (VT 1200 s, Leica, USA). For the first 15-20 min, the slices were incubated in a holding chamber at 32°C with a carbogenated cutting solution. After incubation, the slices were transferred to an artificial cerebral spinal fluid (ACSF) containing (mM): 119 NaCl, 2.3 KCl, 1.0 NaH 2 PO 4 , 26 NaHCO 3 , 11 D-(+)-glucose, 1.3 MgSO 4 , and 2.5 CaCl 2 (pH 7.4, with osmolarity of 295-300 mOsm) at room temperature for at least 1 h.
The slices were placed in a recording chamber and constantly perfused with carbogenated ACSF at 25-28°C (TC-324B, Warner Instruments). The perfusion rate was 2.0 mL/min. Layers II/III were identified by the location closing dorsal medial line of slice at low magnification ( Fig. 1A ). Whole-cell patch-clamp recordings were performed with IR-DIC (differential interference contrast) visualization. Recording pipettes (BF150-86-7.5, Sutter Instruments, USA) were pulled in a horizontal pipette puller (P-97, Sutter Instruments) with a tip resistance of 3-5 MΩ. Patch pipettes were filled with a solution containing (in mM): 128 potassium gluconate, 10 Hepes, 10 phosphocreatine sodium salt, 5 lidocaine N-ethyl chloride 1.1 EGTA, 5 ATP magnesium salt, and 0.4 GTP sodium salt. The pH was adjusted to 7.3 with KOH, and osmolarity was adjusted to 300-305 mOsm/L with sucrose. An axopatch 200B amplifier (Molecular Devices) was used to record either currents or membrane potential. Signals were low-pass filtered at 5 kHz and sampled at 20 kHz with a Digidata 1322A and Clampex 9.0 (Molecular Devices). The data were stored on a computer for subsequent off-line analysis. The pyramidal neurons were determined by typical pyramidal cell body and adaptation firing pattern Wu et al. 2009; Zhang and Seguela 2010) . The membrane potential was held at −70 mV. Monosynaptic EPSCs were evoked with a bipolar platinum electrode (FHC) placed in layer V/VI. DSE recording was performed at 30-32°C with 25 μM bicuculline methochloride added to the recording solution. Before DSE recording, we recorded a baseline measurement at 0.2 Hz for 5 min. When the fluctuation of EPSCs was within 5%, we performed a protocol to elicit DSE. DSE was elicited by depolarizing the postsynaptic cell to 0 mV for 2 s followed by continued recording at 0.2 Hz.
Calcium Image
Using Thy1-GCaMP3 transgenic mice, we performed calcium imaging according to published procedures . Fluorescent signals were imaged by a confocal microscope (Fluoview FV 1200; Olympus) with a 30 mW multiline argon laser at 5-10% laser power. The wavelength of the laser for excitation was 488 nm. The band-pass filter was 505-525 nm. We acquired images with a 5 Hz scanning speed using 20× objectives (NA = 0.75). XYT image galleries were collected, and we measured the average fluorescence intensity of the soma for the quantification with Fluoview data processing software. We reported time series as ΔF/F = (F -F 0 )/(F 0 -F B ). In this formula, F is the raw fluorescence signal; F B is the background; and F 0 is the mean fluorescence signal in a baseline period prior to the DHPG (100 μM, Tocris, UK) bath.
Western Blot
Mice ACC tissues were collected 7 days after CFA injection and lysed in 100-300 μL of RIPA lysis buffer (10 mM Tris, 150 mM NaCl, 1% Triton X-100, 0.5% NP-40, and 1 mM EDTA at pH 7.4) containing a 1:100 (v/v) ratio of a protease inhibitor cocktail and a phosphatase inhibitor cocktail (Roche). We used the BCA protein assay (Pierce) to quantify the total protein samples (20-40 μg), then the samples were resolved via sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred to PVDF membranes. The primary antibodies were as follows: antiβ-actin (1:2000, Cell Signaling Technology); anti-mGluR5 (1:1000, Abcam); and anti-CB1R (1:200, Santa Cruz Biotechnologies). All western blots were visualized using the enhanced chemiluminescence (ECL) detection method (Advansta). The scanned images were quantified using Image J software (version 1.47).
Statistical Analysis
Data were presented as the mean ± SEM. Student's t-test, a paired t-test, and one-way, two-way ANOVAs followed by post hoc Tukey's multiple comparison tests were used to identify significant differences. In all cases, P < 0.05 was regarded as statistically significant.
Results
s Depolarization Elicited DSE in ACC Pyramidal Cells
To explore the possibility of DSE induction in the ACC, we performed whole-cell patch-clamp recordings from pyramidal neurons in layer II/III, while the stimulation electrodes were placed in layer V/VI (Fig. 1A) . We recorded eEPSCs at 0.2 Hz for baseline. The membrane potential was held at −70 mV, and the amplitude of eEPSCs was adjusted to less than 500 pA. After recording stable baseline eEPSCs for at least 5 min, we delivered a DSE induction protocol. We elicited DSE by depolarizing the postsynaptic cell to 0 mV for 2 s (Fig. 1B) , after which, a 0.2 Hz recording was immediately performed. As expected, 2 s depolarization produced a small but significant depression response (normalized EPSCs after depolarization: 73.4 ± 15.5%; n = 11 neurons/5 mice, two-tailed paired t-test, t = 5.418, P = 0.0003; Fig. 1C ,D,E), and the depression would be eliminated within 20 s. We also explored whether a shorter depolarization time would also work for DSE induction. We set a 500 ms and 1 s depolarization time as a comparison to a 2 s depolarization, and we found a lower suppression rate of 500 ms and 1 s depolarization (n = 7 neurons/3 mice;one-way ANOVA; F(2,6) = 63.1; P < 0.0001; Tukey's multiple comparisons test; 500 ms vs. 1 s, q = 2.925; 500 ms vs. 2 s, q = 18.12; 1 s vs. 2 s, q = 11.31; Fig. 1F,G) . These results suggested that the suppression rate occurred in a timedependent manner, and the protocol of 2 s depolarization, on the one hand, minimized intracellular stimulation. On the other hand, it maximized the suppression rate.
Then, we wanted to clarify the mechanism of this DSE produced by 2 s depolarization in the ACC. According to previous reports, Ca 2+ influx plays an important role in DSE induction. To verify whether DSE in the ACC shared the same mechanism, the following procedure was performed. First, we found the DSE was abolished by an internal solution containing 10 mM BAPTA to chelate Ca 2+ influx (normalized EPSCs after depolarization: 100.4 ± 8.4%; n = 8 neurons/3 mice, two-tailed paired t test, t = 0.078, P = 0.9403; Fig. 2A-C) . Previous research has also suggested mGluR5 facilitates the DSE induction in the striatum (Uchigashima et al. 2007 ). We tested it with a bath containing 10 μM MPEP, a selective mGluR5 antagonist (Gasparini et al. 1999; Mitchell et al. 2011) , during the induction protocol and found a tiny DSE (two-tailed paired t test, t = 2.38, P = 0.04; Supplementary Fig. S1A-C) . However, the suppression ratio was significantly reduced compared with the ACSF bath (n = 9 neurons/3 mice, two-tailed unpaired t test, t = 2.97, P = 0.0082; Supplementary Fig. S1G ). Since MPEP is also a positive allosteric modulator of mGluR4 receptor (Mathiesen et al. 2003 ). So we used 3-((2-methyl-1,3-thiazol-4-yl) ethynyl) pyridine hydrochloride (MTEP, 10 μM), another selective and noncompetitive mGlu5 antagonist (Kiritoshi et al. 2013) , to perfuse the slice and induce the DSE. The DSE was still existed but the suppression ratio was also reduced (DSE: n = 7 neurons/2 mice, two-tailed paired t test, t = 2.65, P = 0.04, Fig. 2D -F; Suppression ratio: n = 11 neurons/3 mice for ACSF, n = 7 neurons/2 mice for MTEP, two-tailed unpaired t test, t = 2.81, P = 0.01, Fig. 2G ).
Next, CB1R was found to be the presynaptic target of DSE in many brain areas. Indeed, when the slice was perfused with ACSF containing the CB1R antagonist SR141716A (2 μM) or AM251(5 μM), the amplitude of eEPSCs was similar to baseline (SR141716A: n = 7 neurons/2 mice, t = 0.87, P = 0.42; AM251: n = 8 neurons/3 mice, t = 0.031, P = 0.9760; two-tailed paired t test; Fig. 2H-M) . Finally, we applied CPCCOEt, a mGluR1 receptor antagonist, to check if it had the blocking effect on the DSE. We found that the DSE still could be induced with CPCCOEt bathing (n = 6 neurons/2 mice, t = 4.29, P = 0.008; two-tailed paired t test; Supplementary Fig. S1D-F) . And the suppression ratio of CPCCOEt was similar with ACSF bathing and significant higher than both MPEP and MTEP bathing (one-way ANOVA and Tukey's multiple comparisons test, CPCCOEt vs. MTEP, P = 0.04; CPCCOEt vs. MPEP, P = 0.009; CPCCOEt vs. ACSF, P = 0.99; Supplementary Fig. S1G ). Taking together, our results suggested that 2 s depolarization could elicit a time-dependent DSE, and CB1R and Ca 2+ were necessary for DSE induction, which was a process that mGluR5 also could modulate. 
Inflammatory Pain Impaired DSE Due to Decreasing Expression and Dysfunction of mGluR5
To explore the changes of DSE in pain conditions, we used a CFA-induced chronic inflammatory pain model. After CFA injection, the von Frey and Hargreaves' tests were used to measure the mechanical and thermal response thresholds. The results showed that mechanical and thermal hyperalgesia continued to 12th days after CFA treatment compared with the saline group (CFA group: n = 7; Saline group: n = 7; two-way ANOVA; Group: PWT, F(1,60) = 334.2; P < 0.0001; PWL, F(1,60) = 63.76; P < 0.0001; Group × Time interaction: PWT, F(4,60) = 44.01; P < 0.0001; PWL, F(4,60) = 13.76; P < 0.0001; Fig. 3A,B) . It was similar with previous reports (Gao et al. 2010; Parent et al. 2012 ). Additionally, we performed an open field test to assess the pain-related anxiety at 12th day. We found a significant decrease in the following indicators: distance in central zones (unpaired two-tailed paired t test, t = 22.12; P < 0.0001; Fig. 3E ), the time in central zones (t = 7.675; P < 0.0001; Fig. 3F ), and the percentage of distance mice traveled in the central zones (t = 4.086; P = 0.0015; Fig. 3H ). There were no significant changes in total distance (t = 2.174; P = 0.0505; Fig. 3G ), which indicated that motor ability had not been affected in the CFA group. Our results suggested that CFA treatment would induce anxiety-like behavior at 12th day in addition to the hypersensitivity to pain.
We then performed a DSE recording in mice after finishing the behavior test. In the saline group, we successfully elicited DSE, which was similar to previous results ( Figs 4A and 1C,D,E) . However, impairment of DSE was observed in the CFA group (Fig. 4B) . The suppression ratio of the CFA model was much lower compared with the saline group (CFA group: n = 10 neurons/3 mice; Saline group: n = 10 neurons/3 mice; Saline group vs. CFA group: 21.68 ± 3.48% vs. 5.5 ± 2.99%; unpaired two-tailed paired t test, t = 11.14; P < 0.0001. Fig. 4C,D ).
Next, we tested elements that contributed to the impairment of DSE. First, we performed western blotting to assess the expression of mGluR5 and CB1R protein. We found decreased expression of mGluR5 (n = 6; unpaired two-tailed paired t test, t = 8.531; P < 0.0001) but not CB1R (n = 6; t = 1.569; P = 0.1477) in the CFA model ( Fig. 5A,B ). Then, we performed calcium imaging to explore the functional changes of mGluR5 using DHPGinduced calcium influx in an ACC slice from GCaMP 3.0 mice. As is shown in Figure 5C -E, after a 100 μM DHPG bathing, we observed an increased calcium signal both in the saline group (n = 8 neurons/3 mice; ΔF/F = 2.24 ± 0.44) and the CFA group (n = 8 neurons/3 mice; ΔF/F = 1.13 ± 0.43). However, the increased amplitude of CFA was much lower compared with the saline group (one-way ANOVA with Tukey's multiple comparisons test; q = 7.449; P = 0.003). Since DHPG is also a mGluR1 receptor agonist (Ito et al. 1992) , to further confirm the calcium signal we observed was triggered by mGluR5, we added 10 μM MPEP to the ACSF to block mGluR5 activity and recorded the calcium signal in a DHPG bathing. Indeed, the calcium signal of MPEP was lower compared with the signal in a saline bath (ΔF/F of Saline vs. MPEP: 2.24 ± 0. 44 vs. 0.10 ± 0. 07; Tukey's multiple comparisons test; q = 9.024; P < 0.0001). Our results suggested that in CFAinduced inflammatory pain, the expression of mGluR5 was decreased and it led to dysfunction in the ACC. The protein level of CB1R might be not significantly affected.
Then, we chose a mGluR5-positive allosteric modulator, CDPPB (3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)) to activate mGluR5 in slices and determine whether CDPPB would have any effects on DSE in the CFA model. We found that the suppression level of DSE was significantly increased after a CDPPB (10 μM) bath, both for the saline group and the CFA group (Fig. 6A -D. CFA group: n = 5 neurons/2 mice; Saline group: n = 4 neurons/2 mice; two-tailed paired t test; saline group: t = 4.367; P = 0.022; CFA group: t = 3.451; P = 0.026). Our results indicated that mGluR5 might be an effective method for rescuing CFAinduced DSE impairment in the ACC.
CDPPB Microinjection into ACC Rescued Inflammation-Induced Nociceptive Behavior and Anxiety Behavior
We observed dysfunction and decreased expression of mGluR5, which resulted in the impairment of DSE. And in vitro electrophysiological experiment showed that CDPPB could rescue CFA-induced DSE impairment. Thus, we enhanced the function of mGluR5, aiming to rescue DSE in vivo using CDPPB and to explore the influence of CDPPB on nociceptive behavior and pain-related anxiety. Previous report suggested that 7-days dosing of CDPPB decreased mGluR5 receptor density and phosphorylation in the frontal cortex (Parmentier-Batteur et al. 2012 ). So we decided to do sub-chronical injection to minimize the possibility of mGluR desensitization and micro-administer it directly into the ACC to localize the effect (Fig. 7A ). And the behavior effect of CDPPB indeed depends on the dosage (Uslaner et al. 2009 ). So we also tested different dosages of CDPPB (0.1, 1, and 10 μM with 1% DMSO, 300 nL bilateral injection) and started at 0.1 μM according to previous results (Kinney et al. 2005) . As shown in Figure 7B , we implanted the microtube 4 days before we started to perform pain behavior testing on day 0. Then, we injected CFA on the third day and gave CDPPB on 10th to 12th days. The pain behavior test was performed 30 min after injection immediately on the days with CDPPB injection. An open field test was performed after the last CDPPB treatment.
For pain behavior, we observed that mice recovered from the microtube surgery within the first 3 days. As shown in Figure 7C and D, after CFA treatment on the third day, a significant decrease of PWL was observed in both the von Frey test and Hargreave's test on the 6th and 9th days compared with the saline treatment. CDPPB was given on the 10th, 11th, and 12th days, and mechanical threshold showed elevated trend at 10th and 11th day but did not reach to significant difference when we compared 10 μM CDPPB with other concentrations of CDPPB in CFA group ( Supplementary Fig. S2A,C) . The paw withdrawal latency of 10 μM CDPPB treatment in CFA group was close to same concentration CDPPB in saline group in Hargreave's test (two-way ANOVA with Tukey's multiple comparisons test, saline + 10 μM CDPPB vs. CFA + 10 μM CDPPB: P = 0.098). However, at 11th day, thermal hyperalgesia of 10 μM CDPPB treatment in CFA also was similar with other concentrations of CDPPB in CFA ( Supplementary Fig. S2B,D) . On the 12th day, no difference was observed between the CFA + 10 μM CDPPB group and the Saline + 10 μM DMSO group and significant differences were found between the CFA + 10 μM CDPPB group and other concentrations of CDPPB in CFA groups in both von Frey test and Hargreave's test (two-way ANOVA with Tukey's multiple comparisons test, von Frey test: saline + 10 μM CDPPB vs. CFA + 10 μM CDPPB, P = 0.25; CFA + 10 μM CDPPB vs. CFA + 1 μM CDPPB, P < 0.0001; CFA + 10 μM CDPPB vs. CFA + 0.1 μM CDPPB, P < 0.0001; CFA + 10 μM CDPPB vs. CFA + DMSO, P < 0.0001. Hargreave's test: saline + 10 μM CDPPB vs. CFA + 10 μM CDPPB, P = 0.88; CFA + 10 μM CDPPB vs. CFA+ 1 μM CDPPB, P < 0.0001; CFA + 10 μM CDPPB vs. CFA + 0.1 μM CDPPB, P = 0.0002; CFA + 10 μM CDPPB vs. CFA + DMSO, P < 0.0001; Fig. 7E,F) . Although CDPPB improved nociceptive behavior in CFA model, we also noticed that CDPPB influenced the pain behavior very little in the saline group. There was no significant difference between the Saline + DMSO group and the Saline + CDPPB group (Fig. 7E,F) .
As for the open field test, after analysis of the motion trails, we found that both CFA + 1 μM CDPPB group and the CFA + 10 μM CDPPB group had increasing central distance comparing with CFA + DMSO groups (two-way ANOVA with Tukey's multiple comparisons test, CFA + DMSO vs. CFA + 1 μM CDPPB, P = 0.048; CFA + DMSO vs. CFA + 10 μM CDPPB: P = 0.002; Fig. 7G ), time in central zone (two-way ANOVA with Tukey's multiple comparisons test, CFA + DMSO vs. CFA + 1 μM CDPPB, P = 0.01; CFA + DMSO vs. CFA + 10 μM CDPPB: P = 0.0002; Fig. 7H ). Interestingly, we also found an increase in time in the central zones on the percentage of central distance in the Saline + 10 μM CDPPB group compared with the Saline + DMSO group (Tukey's multiple comparisons test, P = 0.001). For total distance, no differences were observed among all groups (Oneway ANOVA, F = 2.05; P = 0.07; Supplementary Fig. S3 ). Our results suggested that CDPPB has a pain alleviating effect only for the pain condition at the dosage of 10 μM, but it was obviously a function of antianxiety in the pain model with 1 μM dosage and also in control groups with 10 μM dosage. The microtubes reconfirmed the correct treatment location in the ACC and were used for data analysis ( Supplementary Fig. S4 ).
Discussion
In this study, we found that DSE could be induced in ACC pyramidal cells and mediated by eCB signaling and modulated by mGluR5. The suppression level of DSE was reduced due to decreased expression and dysfunction of mGluR5 in the ACC in a mouse model of CFA-induced chronic inflammatory pain. Enhancing the mGluR5 activity with CDPPB could rescue inflammation-induced nociceptive behavior and anxiety behavior.
The ACC was found to be involved in pain and pain-related emotion processing, including anxiety. For the anatomy connection, the ACC receives nociceptive information from the thalamus, amygdala and other pain-related areas of the cortex and is also connecting to the affective processing network that regulates emotions (Apps et al. 2016; Bliss et al. 2016; Williams 2016) . Clinical and experimental researches suggest that the ACC is activated or enhanced in normal pain perception, chronic pain conditions and anxiety disorders (Osuch et al. 2000; Apkarian et al. 2005; Bushnell et al. 2013; Hubbard et al. 2015) . But the exact relationship of pain and pain-related anxiety processing in ACC still remain elusive. Recently, Zhuo proposed the ACC regulate pain and pain-related anxiety with different mechanisms: presynaptic LTP is involved in anxiety triggered by chronic pain but postsynaptic LTP plays a more important role in behavioral sensitization in chronic pain (Zhuo 2016) .We found that the CFA pain mouse model showed anxiety-like behavior and a lower level of DSE in the pyramidal cells of the ACC. It supported the idea of the ACC participating in both pain and pain-related anxiety behavior. We found that both pain and anxiety behaviors were rescued by a mGluR5positive allosteric modulator, CDPPB, which suggested that mGluR5 modulated DSE in the ACC might be one of common targets of chronic inflammatory pain and pain-related anxiety. However, we found that CDPPB did not have an effect on the saline group for pain behavior but did have an antianxiety effect in the saline group for open field test. And the concentration for anxiety relief is one-10th of concentration for pain relief (Fig. 7) . One possibility is that mGluR5-mediated shortterm plasticity changes may be more sensitive in anxiety-like behaviors compared with pain behavior. Another explanation is that the ACC may be more sensitive to the anxiety process than to nociceptive perception. To tell them apart, an experiment of specific activation of the nociceptive or anxiety pathways in ACC could be conducted with optogenetics tools and checking the behavior outcomes.
As a short-term synaptic plasticity with glutamatergic transmission, DSE is triggered by membrane potential changes of postsynaptic neurons and reacts to presynaptic neurotransmitter release. These characteristics reflect the delicate interaction between postsynaptic and presynaptic neuron activity and were found in areas, such as the cerebellum, hippocampus, and amygdala. eCB and the CB1 receptor are the key elements of this synaptic plasticity (Kreitzer and Regehr 2001; Ohno-Shosaku et al. 2002; Diana and Marty 2004; Kodirov et al. 2010) . As a presynaptic target of DSE, the CB1 receptor was moderately expressed in the ACC (Mailleux and Vanderhaeghen 1992; Glass et al. 1997; Tsou et al. 1998) . Our results suggested that DSE can be induced in the pyramidal cells of layers II/III in ACC. Compared with the hippocampus and cerebellum, the DSE of pyramidal cells showed less suppression in the ACC (approximately 20%, Fig. 1 ), which can be explained by the lower expression of CB1 receptors in the ACC. Besides CB1 receptors, mGluR5 also could modulate the expression level of DSE in ACC. It is similar with the reports of DSE in the striatum (Uchigashima et al. 2007) . Previous research has reported that the ACC is involved in chronic pain and related emotional changes, such as anxiety (Osuch et al. 2000; Apkarian et al. 2005; Bliss et al. 2016) . Additionally, eCB signaling proved to be important in mood disorders (Kamprath et al. 2010; Ruehle et al. 2013 ). Our results demonstrated a possible pre-to postsynaptic neuron interaction mechanism for modulating the function of the ACC.
DSE was not only involved in the physiological synaptic transmission but also in several disease conditions. There is evidence that suggests that DSE could be changed in chronic stress, epilepsy and an animal model of Fragile X Syndrome (Li et al. 2012; Straiker et al. 2013; Haj-Dahmane and Shen 2014) . We also found that the suppression level of DSE was reduced in the ACC in a mouse model of inflammatory pain. Changes of long-term synaptic plasticity and intrinsic plasticity through presynaptic, postsynaptic and even astrocytic mechanisms were found to be involved in the functional regulation of the ACC in inflammatory pain conditions (Wu et al. , 2008 Ikeda et al. 2013; Lu et al. 2014; Bliss et al. 2016) . Our finding provides a new possible pain-related information processing strategy for the ACC, which could not only fill in the gap between excitability and synaptic plasticity but also between short-term and long-term synaptic plasticity. We suggested that the reduction of DSE was mainly caused by mGluR5 expression and function in chronic inflammatory pain mouse model. And the protein level of CB1 receptor remained relative normal. However, previous results also found that CB1 receptor showed a decreased expression in rat's periaqueductal gray (PAG) or desensitization in mice's rostral ACC in the chronic constriction injury (CCI) model of neuropathic pain (Hoot et al. 2010; Palazzo et al. 2012) . So our finding could not exclude other possibility, such as calcium channels dysfunction and CB1 receptor desensitization, in DSE reduction in inflammation pain model. The further work need to do for testing these hypotheses in the inflammatory pain mouse model in the future. mGluR5 is widely expressed in dendritic spines and the shafts of the cortex, including the ACC (Romano et al. 1995) . Currently, mGluR5 is thought to be an excellent candidate for chronic pain modulation from the peripheral nervous system to the central nervous system. And previous results found that mGluR5 played a role of antinociception through eCB signaling in the PAG of rat in normal condition and formalin-induced pain condition (Palazzo et al. 2001; de Novellis et al. 2005) . We suggested that the reduction of DSE in the ACC may be related to the decrease in the mGluR5 protein level and function in CFAinduced pain model. The activation of mGluR5 in ACC could provide relief from both pain and pain-related anxiety through eCB mediated DSE mechanism in this inflammatory pain. These results suggest that DSE may be a possible antinociceptive mechanism of mGluR5 in ACC. However, mGluR5, as a G protein coupled receptor, also shows pronociceptive effects depending on the downstream target of activation (Crock et al. 2012; Masuoka et al. 2015) . Considering the multiple targets of mGluR5, it may be wise to find a way to deliver modulators of mGluR5 with a brain-area specific method to produce antinociceptive effects and avoid the pronociceptive effects. In addition, Group III mGluR7 and mGluR8 also are found in cerebral cortex including ACC (Mercier and Lodge 2014) . And mGluR7 and mGluR8 also are involved in pain and pain-related affective disorder in pain response and different pain model (Palazzo et al. 2008 (Palazzo et al. , 2011 (Palazzo et al. , 2013 (Palazzo et al. , 2015 . It will be interest to test the possible role of mGluR7 and mGluR8 in pain-related information in ACC.
In conclusion, our results indicated that DSE mediated by eCB signaling was involved in the synaptic plasticity changes of the ACC in a model of chronic inflammatory pain. The mGluR5 activity of ACC pyramidal cells was important for modulating the DSE and pain-related behaviors, which suggested that mGluR5 in the ACC may potentially serve as an important target for relieving hyperalgesia and anxiety in future therapy. More electrophysiological and behavioral experiments will be needed to explore the roles of DSE-mGluR-eCB signaling in the ACC.
